期刊文献+

扶正解毒汤联合CAG方案治疗急性髓系白血病19例临床观察 被引量:1

The Centralizer Jiedu Decoction Combined the CAG Patients with Acute Myeloid Leukemia 19 Cases of Clinical Observation
下载PDF
导出
摘要 [目的]观察扶正解毒汤联合CAG方案治疗急性髓系白血病的疗效。[方法]对19例住院急性髓系白血病患者进行中西医结合治疗,CAG方案,阿糖胞苷,10mg/m2,1次/12h,皮下注射。第1~14d,阿柔比星,20mg/次,第1、3、5、7d,粒细胞集落刺激因子(G-CSF),200μg/m2,1次/d,皮下注射,第0~13d,白细胞数大于20×109/L时停用。中药治疗,扶正解毒汤,以扶助正气、驱邪解毒(,白花蛇舌草、黄芪、生地黄、景天三七各20g,太子参、天冬、麦冬、南沙参、北沙参、当归、白术、藤梨根、半枝莲、青黛、龙葵各10g,党参15g)。1剂/d,水煎100mL,早晚口服。连续治疗14d为1疗程。观测临床症状、不良反应。治疗1疗程,判定疗效。[结果]CR11例,PR3例,NR5例,总有效率73.68%。[结论]中药扶正解毒汤联合CAG方案治疗急性髓系白血病效果显著,值得推广使用。 [Objective]To observe the centralizer jiedu decoction combined the CAG scheme,the curative effect of treatment of acute myeloid leukemia.[Results]19 cases of hospitalized patients with acute myeloid leukemia to combine traditional Chinese and western medicine treatment,the CAG,cytarabine,10 mg/m2,1/12 h,subcutaneous injection. 1 ~ 14 d,o gentle than star,20 mg/times,1,3,5,7d,granulocyte colony stimulating factor(g-csf),200 mu G/m2,1/d,subcutaneous injection,0 ~ 13 d,white blood cell count is greater than 20 x 109 / L stopped. Chinese medicine treatment,the centralizer jiedu decoction,in order to help the vital qi,Baihuasheshecao,Huangshi,Shengdihuang,Jingtiansanqi each 20g,Taizishen,Tiandong, Maidong,Nanshashen,Beishashen,Danggui,Baishu,Tengligen,Banzhilian,Qingdai,Longkui every 10g, Dangshen 15g). 1/d boiling water 100 ml,oral sooner or later. Continuous treatment of 14d to 1 course of treatment. Observation of clinical symptoms and adverse reactions. Continuous treatment 1 treatment course, judge curative effect.[Results]CR11,PR3,NR5 example,the total effective rate was 73.68%. Traditional Chinese medicine(TCM).[Conclusion]The centralizer detoxification joint the CAG patients with acute myeloid leukemia effect is remarkable,is worth promoting.
出处 《实用中医内科杂志》 2013年第6S期117-119,共3页 Journal of Practical Traditional Chinese Internal Medicine
关键词 急性髓系白血病 扶正解毒汤 CAG方案 中药治疗 Acute myeloid leukemia The centralizer jiedu decoction The CAG plan Traditional Chinese medicine treatment
  • 相关文献

参考文献7

  • 1华自森,王建伟,宋姝丹,王亚平.当归多糖对K562白血病细胞JAK2、STAT3表达和活化的影响[J].解剖学杂志,2009,32(1):8-11. 被引量:18
  • 2廖斌,葛仁英,陈霞,皇甫真萍,齐彦,宋永平,魏旭东.中药复方君子汤联合环孢霉素A逆转白血病细胞株K562/VCR耐药性的实验研究[J].中国实验血液学杂志,2007,15(4):752-755. 被引量:24
  • 3现代血液病学[M]. 人民军医出版社, 2003.现代血液病学[M]人民军医出版社,2003.
  • 4血液病诊断及疗效标准[M]. 科学出版社, 1998.血液病诊断及疗效标准[M]科学出版社,1998.
  • 5MichaelaGraf,KarinHecht,SusanneReif,RenatePelka‐Fleischer,KarinPfister,HelgaSchmetzer.Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies[J]. European Journal of Haematology . 2004 (2)
  • 6Saito K,Furusawa S,Yamada K,Waga K,Aoyagi A,Koike T,Arimura H,Noguchi M,Yamato H,Sakuma H.[Comparison of low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor to intermediate-dose cytosine arabinoside and mitoxantrone with or without etoposide in the treatment of relapsed acute myeloid leukemia. [Rinshō ketsueki] The Japanese journal of clinical hematology . 1995
  • 7Yamada K,Furusawa S,Saito K,et al.Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study. Leukemia . 1995

二级参考文献16

  • 1胡晶,吴宏.当归多糖对小鼠外周血造血干细胞动员作用的研究[J].中草药,2006,37(12):1835-1838. 被引量:47
  • 2Niu G, Wright K L, Ma Y, et al. Role of STAT3 in regulating p53 expression and function[J]. Mol Cell Biol, 2005, 25:7432-7440.
  • 3Gritsko T, Williams A, Turkson J, et al. Persistent activation of STAT3 signaling induces survivin gene expression and confers re sistance to apoptosis in human breast cancer cells [J]. Clin Cancer Res, 2006, 12(1):11-19.
  • 4Ning Z Q, Li J, Arceci R J. Signal transducer and activator of transcription 3 activation is required for Asp816 mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells[J]. Blood, 2001,97 ( 11 ): 3559-3567.
  • 5Buettner R, More L B, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention[J]. Clin Cancer Res, 2002,8(4) :945-954.
  • 6Nam S, Buettner R, Turkson J. Indirubin derivatives inhibit STAT3 signaling and induce apoptosis in human cancer cells[J]. Proe Natl Acad Sci U S A, 2005,102(17):5998-6003.
  • 7Yu H, Jove R. The STATs of cancer- new molecular targets come of age [J]. Nat Rev Cancer, 2004,4:97-105.
  • 8Nielsen M, Kaestel C G, Eriksen K W, et al. Inhibition of constitutively activated STAT3 correlates with altered Bcl-2/Bax ex pression of Bcl-xL [J]. Leukemia, 1999,13(5):735-738.
  • 9Saharinen P, Ekman N, Sarvas K, et al. The Bmx tyrosine kinase induces activation of the STAT signaling pathway which is specifically inhibited by protein kinase C delta[J]. Blood, 1997, 90(11) :4341-4353.
  • 10Chong C D, Liao J, Lio H, et al. Specific inhibition of STAT3 signal transduction by PLAS3 [J].Science, 1997, 278 (5344):1803-1805.

共引文献44

同被引文献11

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部